FDA Application
-
NDC Search Results on Active Ingredient: aspirin
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
CAFFEINE; ASPIRIN; BUTALBITAL | 52959-370-02 | H.J. Harkins Company Inc. dba Pharma Pac | ANDA086162 | HUMAN PRESCRIPTION DRUG | ANDA |
ASPIRIN | 52959-018-14 | H.J. Harkins Company Inc. dba Pharma Pac | part343 | HUMAN OTC DRUG | OTC monograph final |
ASPIRIN | 52959-018-24 | H.J. Harkins Company Inc. dba Pharma Pac | part343 | HUMAN OTC DRUG | OTC monograph final |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2001-03 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-2000-77 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2035-20 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-08 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-2000-30 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-2000-24 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2003-02 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2035-91 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-09 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; CAFFEINE; ACETAMINOPHEN | 0067-2039-84 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-04 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-2000-83 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 0067-2021-20 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-2000-91 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2001-06 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; CAFFEINE; ACETAMINOPHEN | 0067-2039-91 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 0067-2042-04 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; CAFFEINE; ACETAMINOPHEN | 0067-2039-77 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-8202-03 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 0067-2021-24 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-06 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
DIPHENHYDRAMINE CITRATE; ACETAMINOPHEN; ASPIRIN | 0067-2056-24 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; CAFFEINE; ACETAMINOPHEN | 0067-2039-07 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2001-02 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-01 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 0067-8203-03 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 0067-2042-02 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
-